Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06218199 · ClinicalTrials.gov registry record · Phase 4

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

A Phase 4 study of Heart Failure, Congestive, sponsored by Heart Center Research.

Recruiting
Registry status
Phase 4
Development phase
80
Enrollment target
1
Study location

NCT06218199 is a Phase 4 study of Heart Failure, Congestive that is actively recruiting participants, run by Heart Center Research. The registered enrollment target is 80 participants, below the 640-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06218199, a Phase 4 study of Heart Failure, Congestive, is actively recruiting participants, sponsored by Heart Center Research.

RECRUITING
Registry status
Phase 4
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The DART-HA study is a single-center, open label, trial intended to evaluate the clinical efficacy of standard treatment options for congestive heart failure (observation, diuretic or afterload reduction therapy) in patients without new symptoms who have developed abnormalities of the HeartLogic heart failure diagnostic feature.

Conditions Studied

Heart Failure, Congestive

Interventions

  • DRUG Furosemide
  • DRUG Bumetanide
  • DRUG Torsemide
  • DRUG sacubitril/valsartan
  • DRUG Hydralazine

Study Locations (1)

Alabama

  • Heart Center Research, LLC - Huntsville

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-07-08
Est. Completion 2026-12-31
Phase Phase 4

Sponsor

Heart Center Research

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06218199

The ClinicalTrials.gov registry entry for NCT06218199 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 640-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (87% lower). The listed sponsor is Heart Center Research, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure, Congestive appearing as the primary indexed condition, and to 5 interventions - of which Furosemide is the first listed.

NCT06218199 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06218199 about?

NCT06218199 is a clinical study titled "Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts". The DART-HA study is a single-center, open label, trial intended to evaluate the clinical efficacy of standard treatment options for congestive heart failure (observation, diuretic or afterload reduction therapy) in patients without new symptoms who have developed abnormalities of the HeartLogic hea...

What is the current status of trial NCT06218199?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2021-07-08. Estimated completion is 2026-12-31.

What conditions does trial NCT06218199 study?

This clinical trial studies the following conditions: Heart Failure, Congestive.

What interventions are being tested in trial NCT06218199?

The interventions under investigation include: Furosemide (DRUG), Bumetanide (DRUG), Torsemide (DRUG), sacubitril/valsartan (DRUG), Hydralazine (DRUG).

Who is sponsoring clinical trial NCT06218199?

This trial is sponsored by Heart Center Research, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06218199 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure, Congestive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure, Congestive

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.